ProMIS Neurosciences, Inc.
PMN
$9.75
$0.040.36%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -4.38% | |||
| Gross Profit | -- | 4.38% | |||
| SG&A Expenses | 19.20% | -28.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -19.75% | -8.33% | |||
| Operating Income | 19.75% | 8.33% | |||
| Income Before Tax | 22.76% | 7.82% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 22.76% | 7.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 22.76% | 7.82% | |||
| EBIT | 19.75% | 8.33% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 69.50% | 30.16% | |||
| Normalized Basic EPS | 69.50% | 30.15% | |||
| EPS Diluted | 69.85% | 30.17% | |||
| Normalized Diluted EPS | 69.50% | 30.15% | |||
| Average Basic Shares Outstanding | 153.22% | 31.97% | |||
| Average Diluted Shares Outstanding | 153.22% | 31.97% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||